Effects of Anticoagulant Therapy and Frailty in the Elderly Patients with Atrial Fibrillation.
Jiancao DingYing SunKan ZhangWei HuangMei TangDai ZhangYun-Li XingPublished in: Clinical interventions in aging (2024)
In the elderly patients with NVAF, the decision toward anticoagulation therapy at hospital discharge was influenced by age, bleeding history, paroxysmal atrial fibrillation diagnosis, and absence of thrombosis. Frail patients were at greater risk of bleeding and all-cause mortality. Anticoagulation tended to reduce the risk of thrombotic events.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- community dwelling
- heart failure
- end stage renal disease
- newly diagnosed
- percutaneous coronary intervention
- venous thromboembolism
- patient reported outcomes
- cell therapy
- middle aged
- mesenchymal stem cells
- decision making
- acute coronary syndrome
- bone marrow